Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
United Therapeutics (UTHR)
NASDAQ:UTHR
United Therapeutics (UTHR) Ownership - Who Owns United Therapeutics?
450 Followers
United Therapeutics (UTHR) Ownership Overview
12.16% Insiders
29.53% Mutual Funds
51.80% Other Institutional Investors
6.51% Public Companies and Individual Investors
The ownership structure of United Therapeutics (UTHR) stock is a mix of institutional, retail and individual investors. Approximately 81.33% of the company’s stock is owned by Institutional Investors, 12.16% is owned by Insiders and 6.51% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 16, 2024 | James Edgemond Cfo & Treasurer | Sold | $10951230 |
| May 16, 2024 | James Edgemond Cfo & Treasurer | Bought | $2475628 |
| May 16, 2024 | Christopher Causey Director | Sold | $545800 |
| May 15, 2024 | Christopher Patusky Director | Sold | $346299 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Bought | $481722 | |
| Mar 31, 2024 | Bought | $1107480 | |
| Mar 31, 2024 | Sold | $1826274 | |
| Mar 31, 2024 | Sold | $29852114 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,513,345 | Institution | 10.17% | 1,230,744,048 | |
| 4,509,216 | Institution | 10.16% | 1,229,618,111 | |
| 4,189,384 | Institution | 9.44% | 1,142,403,123 | |
| 1,034,364 | Institution | 2.33% | 282,060,719 | |
| 949,064 | Institution | 2.14% | 258,800,262 | |
| 842,593 | Institution | 1.90% | 229,766,685 | |
| 748,616 | Institution | 1.69% | 204,140,097 | |
| 536,229 | Institution | 1.21% | 146,224,286 | |
| 498,632 | Institution | 1.12% | 135,971,960 | |
| 471,069 | Institution | 1.06% | 128,455,806 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,189,384 | Institution | 9.44% | 1,142,403,123 | |
| 949,064 | Institution | 2.14% | 258,800,262 | |
| 842,593 | Institution | 1.90% | 229,766,685 | |
| 748,616 | Institution | 1.69% | 204,140,097 | |
| 536,229 | Institution | 1.21% | 146,224,286 | |
| 471,069 | Institution | 1.06% | 128,455,806 | |
| 454,730 | Institution | 1.02% | 124,000,324 | |
| 402,982 | Institution | 0.91% | 109,889,162 | |
| 202,917 | Institution | 0.46% | 55,333,437 | |
| 193,863 | Institution | 0.44% | 52,864,501 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,478,775 | Institution | 3.33% | 403,247,155 | |
| 1,479,900 | Institution | 3.34% | 346,784,967 | |
| 1,415,777 | Institution | 3.19% | 301,546,343 | |
| 1,197,705 | Institution | 2.70% | 280,658,213 | |
| 804,278 | Institution | 1.81% | 188,466,464 | |
| 702,051 | Institution | 1.58% | 164,511,611 | |
| 488,323 | Institution | 1.10% | 131,739,779 | |
| 382,564 | Institution | 0.86% | 104,321,377 | |
| 309,488 | Institution | 0.70% | 84,394,283 | |
| 301,679 | Institution | 0.68% | 81,386,961 |
FAQ
Who Owns United Therapeutics (UTHR)?
According to the latest TipRanks data, approximately 51.80% of the company's stock is held by institutional investors, 12.16% is held by insiders, and 6.51% is held by retail investors.
What percentage of United Therapeutics (UTHR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 51.80% of United Therapeutics (UTHR) stock is held by institutional investors.
What percentage of United Therapeutics (UTHR) stock is held by retail investors?
According to the latest TipRanks data, approximately 6.51% of United Therapeutics (UTHR) stock is held by retail investors.
Who owns the most shares of United Therapeutics (UTHR)?
Vanguard owns the most shares of United Therapeutics (UTHR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.